Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Morange

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|April 17, 2015
Genetic determinants of tissue factor pathway inhibitor plasma levelsJ Dennis, I Kassam, P-E Morange, et al.
Clinical and Experimental Rheumatology|August 11, 2004
Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-GuerinB Granel, J Serratrice, P E Morange, et al.
Thrombosis and Haemostasis|April 2, 1999
Rapid detection of factor XIII Val34Leu by allele specific PCRM Henry, P E Morange, I Canavy, et al.
Thrombosis and Haemostasis|July 15, 2000
Plasma TAFI antigen variations in healthy subjectsP Chetaille, M C Alessi, D Kouassi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2008
Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generationC Sanchez, M C Alessi, N Saut, et al.
Journal Des Maladies Vasculaires|January 17, 2009
[Venous thromboembolic disease: questions and controversies. Teaching seminary in vascular medicine (November22, 2007)]M-A Sevestre, P-M Roy, P-E Morange, et al.
Thrombosis and Haemostasis|January 5, 2002
Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriersP E Morange, M F Aillaud, V Nicaud, et al.
Blood|March 27, 2001
Factor XIIIV34L is not an additional genetic risk for venous thrombosis in factor V Leiden carriersP E Morange, M Henry, D Brunet, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|June 15, 2019
[Impact of menstrual blood self-representation on contraceptive choice of women]S Fernandez-Sala, R Rousseau-Durand, P-E Morange, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Juvenile temporal arteritis and activated protein C resistanceB Granel, J Serratrice, N Ene, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|April 17, 2015
Genetic determinants of tissue factor pathway inhibitor plasma levelsJ Dennis, I Kassam, P-E Morange, et al.
Clinical and Experimental Rheumatology|August 11, 2004
Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-GuerinB Granel, J Serratrice, P E Morange, et al.
Thrombosis and Haemostasis|April 2, 1999
Rapid detection of factor XIII Val34Leu by allele specific PCRM Henry, P E Morange, I Canavy, et al.
Thrombosis and Haemostasis|July 15, 2000
Plasma TAFI antigen variations in healthy subjectsP Chetaille, M C Alessi, D Kouassi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 3, 2008
Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generationC Sanchez, M C Alessi, N Saut, et al.
Journal Des Maladies Vasculaires|January 17, 2009
[Venous thromboembolic disease: questions and controversies. Teaching seminary in vascular medicine (November22, 2007)]M-A Sevestre, P-M Roy, P-E Morange, et al.
Thrombosis and Haemostasis|January 5, 2002
Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriersP E Morange, M F Aillaud, V Nicaud, et al.
Blood|March 27, 2001
Factor XIIIV34L is not an additional genetic risk for venous thrombosis in factor V Leiden carriersP E Morange, M Henry, D Brunet, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|June 15, 2019
[Impact of menstrual blood self-representation on contraceptive choice of women]S Fernandez-Sala, R Rousseau-Durand, P-E Morange, et al.
Annals of the Rheumatic Diseases|January 15, 2004
Juvenile temporal arteritis and activated protein C resistanceB Granel, J Serratrice, N Ene, et al.
Pageof 8